Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06927882

Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Cognitive Impairment

Effects of Whole Body Vibration Therapy on Cognitive Function, Balance, and Quality of Life in Older Adults With Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
180 (estimated)
Sponsor
Jouf University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

This is a double-blind, randomized controlled trial comparing WBV therapy with a placebo intervention and standard care. A total of 150 participants will be recruited and investigated from Prince Mutib Hospital. Participants will be randomly allocated to one of three groups: WBV therapy, placebo (non-vibrating platform), or control (standard care). The study duration will be 12 weeks, with assessments conducted at baseline, post-intervention (12 weeks), and at a 6-month follow-up. Protocol Parameters Summary * Session Frequency: 3 times per week. * Session Duration: 25 minutes per session. * Vibration Frequency: 30 Hz. * Amplitude: 1-2 mm. * Program Duration: 12 weeks.

Conditions

Interventions

TypeNameDescription
OTHERWBV Therapy Group* Frequency: 3 sessions per week for 12 weeks. * Duration: 25 minutes per session. * Vibration Parameters: Participants will undergo whole body vibration therapy at a frequency of 30 Hz, for 25 minutes per session, 3 times a week, with an amplitude of 1-2 mm, over a duration of 12 weeks.
OTHERPlacebo Group:• Participants will stand on a non-vibrating platform and perform similar static and dynamic exercises for the same duration. The platform will mimic the active intervention's noise and display settings to maintain blinding.
OTHERControlOnly assessment at baseline, after 12 weeks and 6 months.

Timeline

Start date
2025-11-15
Primary completion
2025-12-30
Completion
2025-12-30
First posted
2025-04-15
Last updated
2025-11-17

Source: ClinicalTrials.gov record NCT06927882. Inclusion in this directory is not an endorsement.